Table 3 Characteristics of patients without clinical complete response

From: Chemoradiotherapy with capecitabine for locally advanced anal carcinoma: an alternative treatment option

 

5-FU+MMC ( n =5)

Capecitabine+MMC ( n =6)

 

Characteristic

No.

%

No.

%

P -value

Age (years), median (range)

65.6 (36.8–73.5)

56.2 (41.3–65.1)

0.545

Gender

Male

3

60

5

83

0.559

Female

2

40

1

17

 

T-classification

T1

0

0

0

0

0.177

T2

2

40

0

0

 

T3

2

40

3

50

 

T4

1

20

3

50

 

N-classification

N0

2

40

1

17

0.086

N1

1

20

0

0

 

N2

2

40

2

33

 

N3

0

0

3

50

 

HIV status

Negative

0

0

4

67

0.333

Positive

1

20

1

17

 

Not known

4

80

1

17

 

Primary tumor site

Anal canal

6

100

6

100

1.000

Anal margin

0

0

0

0

 

Both

0

0

0

0

 
  1. Abbreviations: 5-FU=5-fluorouracil; LN=lymph node; MMC=mitomycin C.